Insulet traded at $228.21 this Monday June 27th, increasing $0.48 or 0.21 percent since the previous trading session. Looking back, over the last four weeks, Insulet gained 6.90 percent. Over the last 12 months, its price fell by 19.43 percent. Looking ahead, we forecast Insulet to be priced at 221.60 by the end of this quarter and at 204.20 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 254.78 -0.54 -0.21% -18.45%
Abbott 109.08 -0.37 -0.34% -5.72%
Align Technology 250.17 -8.58 -3.32% -59.75%
AtriCure 40.71 -0.21 -0.51% -49.00%
Avanos Medical Inc 26.76 0.18 0.68% -28.83%
Baxter International 66.71 -0.07 -0.10% -18.30%
Becton, Dickinson and Co. 250.10 -0.82 -0.33% 2.63%
Boston Scientific 37.82 -0.20 -0.53% -12.72%
Cardinal Health 54.86 0.41 0.75% -4.17%
Cooper Companies 322.07 -1.42 -0.44% -18.57%
Cardiovascular Systems 14.81 -0.16 -1.07% -65.58%
Dexcom 76.60 -1.07 -1.38% -82.07%
Edwards Lifesciences 96.81 -0.17 -0.18% -5.62%
Globus Medical 58.71 0.86 1.49% -22.83%
Integra LifeSciences 55.00 0.51 0.94% -19.73%
ICU Medical 169.40 -0.02 -0.01% -17.53%
Inogen 25.63 -0.53 -2.03% -61.37%
J&J 182.12 -0.17 -0.09% 11.04%
Eli Lilly 327.27 1.65 0.51% 43.40%
Masimo 139.80 1.20 0.87% -43.67%
Medtronic 90.47 0.25 0.28% -26.89%
Merit Medical Systems 54.88 1.94 3.66% -14.58%
NuVasive 50.88 0.21 0.41% -26.30%
Insulet 228.21 0.48 0.21% -19.43%
Roche Holding 322.55 3.75 1.18% -7.33%
Sientra 0.95 -0.05 -4.72% -87.09%
Stryker 203.13 -1.30 -0.64% -21.98%
Teleflex 259.56 1.51 0.59% -36.13%
Tandem Diabetes Care 60.99 -0.53 -0.86% -38.70%
West Pharmaceutical Services 304.82 3.64 1.21% -16.07%
Zimmer Biomet Holdings Inc 108.51 -0.36 -0.33% -33.71%

Indexes Price Day Year
USND 11525 -83.07 -0.72% -20.52%
US2000 1772 6.01 0.34% -23.71%

Insulet
Insulet Corporation is primarily engaged in the development, manufacture and sale of its proprietary Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) and a Personal Diabetes Manager (PDM). Users has to fill the Pod with insulin and wear directly on the body. It can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back. The Pod delivers precise, personalized doses of insulin into the body through a small flexible tube, cannula. PDM is a wireless, handheld device that programs the Pod with the user’s personalized insulin-delivery instructions and wirelessly monitors the Pod’s operation.